Foto del docente

Angela Montanari

Professoressa ordinaria

Dipartimento di Scienze Statistiche "Paolo Fortunati"

Settore scientifico disciplinare: STAT-01/A Statistica

Coordinatrice del Corso di Dottorato in Scienze statistiche

Didattica

Ultime tesi seguite dal docente

Tesi di Laurea

  • Analisi della performance fisica di una squadra di calcio militante in Serie BKT
  • Anomaly detection on declared crop type using satellite indexes: a Machine Learning approach
  • Bayesian Analysis of Crime Statistics
  • Comparative Analysis of Machine Learning Algorithms for Clinical Outcome Prediction
  • Dimension reduction: PCA and GPLVM for Simulated Cylinder and Real Handwritten Digits
  • Joint distribution for the number of occupied boxes across different layers in generalised allocation process
  • Maximal Occupancy in Generalised Allocation Process
  • Modelling Alcohol Intake with the NDNS for the UK Adult Population
  • Modelling Atmospheric CO2 Level with Gaussian Process Regression Models
  • Previsione dello stipendio dei cestisti NBA tramite modelli di regressione multipla
  • Selezioni delle variabili in un modello di regressione multiplo mediante proiezioni casuali
  • Stima dei parametri del modello di regressione multipla utilizzando stime ben condizionate della matrice di covarianza dei predittori
  • Student Perspective of Teaching Excellence
  • Text and sentiment analysis delle candidature per l'esperienza Erasmus+
  • The Scottish Index of Multiple Deprivation. Analysis, Comparison and Limitations
  • Transition Risk Analysis: un'applicazione del metodo Lasso
  • Visualising the effects of predictor variables in black box models: A Study of PDP and ALE plots with the Pima Indians Diabetes dataset
  • Weather Forecasting using Recurrent Neural Networks
  • What makes a good wine?

Tesi di Laurea Magistrale

  • A Statistical Evaluation on Modified Simon's II Stage Design Approach in Clinical Trials
  • Causal inference in randomized clinical trials: a case study
  • Identification of clonotype for monitoring minimal residual disease in newly diagnosed multiple myeloma patients
  • SECOND-LINE THERAPY WITH DARATUMUMAB-BORTEZOMIB-DEXAMETHASONE (DaraVD) FOR MULTIPLE MYELOMA (MM) PATIENTS REFRACTORY TO LENALIDOMIDE: RESULTS OF A MULTICENTER OBSERVATIONAL STUDY